Colombia Sessions: Contest for Young Interventionists

Sponsored by Abbott Vascular LATAM

34th SOLACI Regional Sessions – 11° Andrean Region.

October 5th and 6th, 2017.
Bogotá, Colombia.


Case Submission: “Fostering Hemodynamics among Young Cardiologists”.

It is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Bogotá, Colombia, to be held on October 5th and 6th, 2017.

Participants will be competing for the “best case” prize, which consists of complete coverage to attend to a SOLACI Session, including air fare, accommodation and registration. Winner will have the chance to choose amongst an upcoming SOLACI Session.

 

Submitted cases must be of educational value and must pertain to the field of interventional cardiology.

 

All cases will be initially evaluated by the appointed committee and shortlisted to the best 8, which shall be presented orally during our sessions. During these presentations, a second complementary evaluation will decide on the winner.

 

Case submission deadline: September 21st, 2017.

 

 Submission Criteria and Specifications:

 

  • Case submission is meant for young Latin American interventional cardiologists and topics include: adult peripheral vascular and structural heart interventional cardiology.

 

  • In each case only one interventionist can sign. Being a fellow cardiologist or interventionist is not required.

 

  • Attach a letter of recommendation from the Chief of the Hemodynamic Service you belong to.

 

  • Send a Word file with your case description, no longer than 300 words, font size 11.

 

  • Send a complementary Power Point file with your case presentation. Even though you may use videos for your oral presentation during our sessions (up to 5), this initial file may only include up to 5 pictures only.

 

  • One cardiologist may present more than one case. If such were the case, they should be sent separately.

 

  • Cases shall be submitted via this 

 

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...